| Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation CE Staatz, SE Tett Clinical pharmacokinetics 43, 623-653, 2004 | 1020 | 2004 |
| Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients CE Staatz, SE Tett Clinical pharmacokinetics 46, 13-58, 2007 | 693 | 2007 |
| Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I CE Staatz, LK Goodman, SE Tett Clinical pharmacokinetics 49, 141-175, 2010 | 525 | 2010 |
| Conditional weighted residuals (CWRES): a model diagnostic for the FOCE method AC Hooker, CE Staatz, MO Karlsson Pharmaceutical research 24, 2187-2197, 2007 | 408 | 2007 |
| Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation DRJ Kuypers, Y Le Meur, M Cantarovich, MJ Tredger, SE Tett, D Cattaneo, ... Clinical journal of the American Society of Nephrology 5 (2), 341-358, 2010 | 366 | 2010 |
| Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in … MH Abdul-Aziz, H Sulaiman, MB Mat-Nor, V Rai, KK Wong, MS Hasan, ... Intensive care medicine 42, 1535-1545, 2016 | 314 | 2016 |
| PharmGKB summary: cyclosporine and tacrolimus pathways JM Barbarino, CE Staatz, R Venkataramanan, TE Klein, RB Altman Pharmacogenetics and genomics 23 (10), 563-585, 2013 | 286 | 2013 |
| Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update CE Staatz, SE Tett Archives of toxicology 88, 1351-1389, 2014 | 211 | 2014 |
| Population pharmacokinetics of tacrolimus in adult kidney transplant recipients CE Staatz, C Willis, PJ Taylor, SE Tett Clinical Pharmacology & Therapeutics 72 (6), 660-669, 2002 | 193 | 2002 |
| Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation C Staatz, P Taylor, S Tett Nephrology Dialysis Transplantation 16 (9), 1905-1909, 2001 | 187 | 2001 |
| Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations AH Thomson, CE Staatz, CM Tobin, M Gall, AM Lovering Journal of antimicrobial chemotherapy 63 (5), 1050-1057, 2009 | 171 | 2009 |
| Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure SE Tett, F Saint-Marcoux, CE Staatz, M Brunet, AA Vinks, M Miura, ... Transplantation reviews 25 (2), 47-57, 2011 | 158 | 2011 |
| Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation TK Bergmann, KA Barraclough, KJ Lee, CE Staatz Clinical pharmacokinetics 51, 711-741, 2012 | 150 | 2012 |
| Predictors of new onset diabetes after renal transplantation N Joss, CE Staatz, AH Thomson, AG Jardine Clinical transplantation 21 (1), 136-143, 2007 | 128 | 2007 |
| Once-versus twice-daily tacrolimus: are the formulations truly equivalent? KA Barraclough, NM Isbel, DW Johnson, SB Campbell, CE Staatz Drugs 71, 1561-1577, 2011 | 126 | 2011 |
| Clinical pharmacokinetics of once-daily tacrolimus in solid-organ transplant patients CE Staatz, SE Tett Clinical pharmacokinetics 54, 993-1025, 2015 | 103 | 2015 |
| Toward better outcomes with tacrolimus therapy: population pharmacokinetics and individualized dosage prediction in adult liver transplantation CE Staatz, C Willis, PJ Taylor, SV Lynch, SE Tett Liver Transplantation 9 (2), 130-137, 2003 | 102 | 2003 |
| Population pharmacokinetic modelling and Bayesian estimation of tacrolimus exposure: is this clinically useful for dosage prediction yet? E Brooks, SE Tett, NM Isbel, CE Staatz Clinical pharmacokinetics 55, 1295-1335, 2016 | 101 | 2016 |
| Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of: CYP3A5: Genotype on Starting Dose TK Bergmann, S Hennig, KA Barraclough, NM Isbel, CE Staatz Therapeutic drug monitoring 36 (1), 62-70, 2014 | 95 | 2014 |
| Population pharmacokinetics of mycophenolic acid during the first week after renal transplantation CE Staatz, SB Duffull, B Kiberd, AD Fraser, SE Tett European journal of clinical pharmacology 61, 507-516, 2005 | 82 | 2005 |
